Azenta Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/14/2026)
| Balance Sheet | Total Assets | 2,034,010,000.00 | ROE | 83.36 % |
| Balance Sheet | Total Equity | 1,695,450,000.00 | ROA | -2.74 % |
| Cashflow | Capital Expenditures | -33,857,000.00 | P/FCF | 44.53 |
| Cashflow | Free Cash Flow | 38,324,000.00 | – | – |
| Cashflow | Operating Cash Flow | 72,181,000.00 | P/CF | 23.64 |
| Income | Earnings per Share (diluted) | -1.21 | Div. Yield | – |
| Income | Net Income | -59,503,000.00 | P/E | -30.73 |
| Income | Shares Outstanding | 45,858,979.00 | P/B | 1.01 |
| Income | Total Revenue | 593,821,000.00 | P/S | 2.87 |
Ratios calculated on: 10/14/2026
Company Description
Brooks Automation, Inc. (Brooks) is a global provider of automation, vacuum and instrumentation solutions for multiple markets, including semiconductor manufacturing, technology device manufacturing and life sciences. The Company operates in four segments: Brooks Product Solutions, Brooks Global Services and Brooks Life Science Systems. On December 30, 2011, the Company acquired the Celigo automated Cell Cytometer product line (Celigo) from Cyntellect, Inc. On January 6, 2012, the Company acquired intangible assets from Intevac, Inc. On October 29, 2012, it acquired Crossing Automation Inc. (Crossing), a United States based provider of automation solutions for the global semiconductor front-end markets.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.brooks.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more